Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111363736A reveals a novel enzymatic route for dexketoprofen using Klebsiella amidase, offering superior ee values and greener manufacturing for pharmaceutical intermediates.
Novel patent CN116496239A offers a green synthesis route for Venetoclax intermediates, ensuring high purity and supply chain reliability for global pharmaceutical procurement.
Patent CN102719378A reveals high-purity (-)-gamma-lactam production via Delftia sp., offering cost-effective API manufacturing solutions.
Novel C-H activation synthesis of high-B-ring berberine derivatives offers potent IDO1/TDO inhibition for oncology drug development.
Novel patent CN116410098B enables catalyst-free oxidation using sodium percarbonate for high-purity alpha-amino ketones ensuring supply chain reliability and cost efficiency.
Novel synthetic route for Entecavir using Corey lactone diol, offering cost reduction and scalability for pharmaceutical manufacturing supply chains.
Patent CN101870704A reveals a room-temperature purification method for cefotetan acid, drastically reducing isomer content and enhancing manufacturing efficiency for pharmaceutical intermediates.
Patent CN116178243A reveals a mild visible-light photocatalytic method for carbazole synthesis, offering significant cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN113234055B reveals a novel copper-polyselenide catalytic system for lactide synthesis, offering high optical purity and recyclable catalysts for cost-effective polylactic acid production.
Patent CN104817496B details metal-free hydrogenation for tetrahydroquinolines. Offers high yield, stereoselectivity, and cost-effective manufacturing for pharmaceutical intermediates.
Novel SCF3 introduction method reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing processes globally.
Patent CN103588833A reveals a novel tulathromycin synthesis avoiding toxic cyanide and expensive palladium, offering significant cost reduction and high purity for veterinary pharmaceutical manufacturing.
Patent CN1179938C details a stereoselective Pd-catalyzed method for vitamin D A-ring synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Discover novel chromone compounds with antitumor activity. Our advanced PPA cyclization process ensures high purity and scalable supply for pharmaceutical manufacturing.
Patent CN115786313A reveals a novel nitrilase mutant boosting 2-chloronicotinic acid yield by 23.2 times, offering a green alternative for pharma and agrochemical intermediates.
Novel synthesis method for polypeptide linkers. High yield, safe, scalable. Cost-effective manufacturing solution for pharmaceutical intermediates.
Novel patent CN108586313B enables high-purity intermediate production with stable raw materials. Significant cost reduction and supply chain reliability for global pharmaceutical manufacturers seeking scalable solutions.
Patent CN105087664A reveals high-yield biocatalytic route for chiral intermediates ensuring supply chain stability and significant cost efficiency for global pharmaceutical manufacturing partners seeking reliable production.
Advanced patent CN107721832A enables high-purity 4-chloro-3-fluorobenzene ether production with streamlined operations for global supply chains.
Patent CN109369631B details a novel enzymatic route for LDHA inhibitor intermediates, offering high ee values and scalable manufacturing for reliable pharmaceutical suppliers.